| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697758 | Clinical Oncology | 2017 | 6 Pages |
Abstract
Only 10% had a complete response. Therefore, a significant number of patients became refractory to radioiodine during a course of repeat admissions for treatment. Dosimetry (often together with thyroglobulin and anatomical scans) helped to identify these patients to avoid further futile radioiodine therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
F. Sun, G.E. Gerrard, J.K. Roberts, T. Telford, S. Namini, M. Waller, G. Flux, V.M. Gill,